reference/31862133

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31862133

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	66
issn	2328-9503
issueIdentifier	1
pageRange	50-66
publicationName	Annals of Clinical and Translational Neurology
startingPage	50
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1504ae43cf1e6ecc34994f503c3f57ce http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2f27b383cca2565ad499e55bb534e669
bibliographicCitation	Katz JS, Rothstein JD, Cudkowicz ME, Genge A, Oskarsson B, Hains AB, Chen C, Galanter J, Burgess BL, Cho W, Kerchner GA, Yeh FL, Ghosh AS, Cheeti S, Brooks L, Honigberg L, Couch JA, Rothenberg ME, Brunstein F, Sharma KR, van den Berg L, Berry JD, Glass JD. A Phase 1 study of GDC‐0134, a dual leucine zipper kinase inhibitor, in ALS. Ann Clin Transl Neurol. 2022 Jan;9(1):50–66. doi: 10.1002/acn3.51491.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_739e4f70e037ad9df13963db0b775c92 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0bfc6fc13e4f1f87d30d8eae6566f7c9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b603a4452a29b57b39c53f32e94c9867 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ef8311569802aa65e13be931f9445fd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bbfb96276e67c90da309af96db4835cb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b8588b0e3f966c88538ec580eba403fb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d63046ebb109456c4c6319ddf5f08823 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21a09cf5e20ce7434c98ac43711d30cd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e000cf73efdb10fe0c0a5c5100360b4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7fdd70026af0abcf94a97a7aeff2779e http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3295-4971 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_001afafbb54c71679c191fc786b84528 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d56038346b8a9fc12e30e5e6b1c79837 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f37a56f4237da2f7bd3e5aedb2dd4c30 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_958a6e7e3fdb7e436a975bfff47db914 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_15f6840ee9ade2f88ea1fea9a25a94f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_42fdabe0c2c5aa2be43d427b7071321b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0af4070f32c2711098c9b57d998e1d6c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_387262c465dabd57b4ad09c50a411139 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cecada3f21798d253c5c3e203f8ad49 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d28bb7dbe9737377edd9a01d8100b355 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f27fb5de901899d604a402e89b25945 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aaa5d0b363404f6b0280df3520a75645
date	202201
identifier	https://doi.org/10.1002/acn3.51491 https://pubmed.ncbi.nlm.nih.gov/35014217 https://pubmed.ncbi.nlm.nih.gov/PMC8791798
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/42131 https://portal.issn.org/resource/ISSN/2328-9503
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A Phase 1 study of GDC‐0134, a dual leucine zipper kinase inhibitor, in ALS
discusses	http://id.nlm.nih.gov/mesh/M0023752 http://id.nlm.nih.gov/mesh/M0239780 http://id.nlm.nih.gov/mesh/M0025716 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0130814 http://id.nlm.nih.gov/mesh/M0328033
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D016900Q000097 http://id.nlm.nih.gov/mesh/D000690Q000188 http://id.nlm.nih.gov/mesh/D047428Q000008 http://id.nlm.nih.gov/mesh/D047428Q000009 http://id.nlm.nih.gov/mesh/D020930Q000037
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D000690Q000097 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D047428Q000493 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D017063 http://id.nlm.nih.gov/mesh/D018345 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D020930Q000172 http://id.nlm.nih.gov/mesh/D015415Q000097 http://id.nlm.nih.gov/mesh/D051379
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_42fc2c84597c9ec39f714142cab5e44d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8636 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8804 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6865 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.11.24 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10326 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1ab93dab864d412d37c9dcb9c25f8a38

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID26404

Total number of triples: 79.